Evidence map›Paper›PMID 37908230›Full record

ArticleFrontiers in molecular biosciences2023

Structural properties of the HNF-1A transactivation domain.

Laura Kind, Mark Driver, Arne Raasakka, Patrick R Onck, Pål Rasmus Njølstad, Thomas Arnesen, Petri Kursula

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Laura KindDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Mark DriverZernike Institute for Advanced Materials, University of Groningen, Groningen, Netherlands.
Arne RaasakkaDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Patrick R OnckZernike Institute for Advanced Materials, University of Groningen, Groningen, Netherlands.
Pål Rasmus NjølstadMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.
Thomas ArnesenDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Petri KursulaDepartment of Biomedicine, University of Bergen, Bergen, Norway.
University of Bergen · NOUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocyte nuclear factor 1α (HNF-1A) is a transcription factor with important gene regulatory roles in pancreatic β-cells.

Indexed as

diabetesHNF-1Aintrinsically disordered proteinliquid-liquid phase separationMODYshort linear motiftranscription factorβ-cell

Identifiers

PMID37908230
PMCPMC10613711
OpenAlexW4387670227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.